Category Archives: Pancreatic Cell

Pancreatic Cell News is an online publication and email newsletter providing updates on the latest pancreatitis, diabetes, and pancreatic cancer research.
Subscribe
Pancreatic Cell News is a weekly newsletter that highlights recent top articles in the field of pancreatic cell research. These articles have been carefully selected from high-impact, peer-reviewed academic journals by our experienced editorial team. We cover topics including pancreatic cell culture, pancreatitis, diabetes, and pancreatic cancer. We also feature the latest industry and policy news alongside job postings and upcoming events to keep scientists current while saving them valuable time.

Foreign Researchers Accused of Hiding Links to Chinese Military

Four Chinese nationals have been charged with visa fraud after revelations that they sent information on the layout of US labs and research carried out by colleagues back to China.
[The Scientist]
Press Release

Continue reading “Foreign Researchers Accused of Hiding Links to Chinese Military”

Bookmark

No account yet? Register

0
Share

A G-Quadruplex-Binding Compound Shows Potent Activity in Human Gemcitabine-Resistant Pancreatic Cancer Cells

Scientists report on cell lines of increased resistance to gemcitabine that have been generated from this line, with the most resistant having 1,000-fold reduced sensitivity to gemcitabine.
[Scientific Reports]
Full Article

Continue reading “A G-Quadruplex-Binding Compound Shows Potent Activity in Human Gemcitabine-Resistant Pancreatic Cancer Cells”

Bookmark

No account yet? Register

0
Share

Methylation of HSP70 Orchestrates Its Binding to and Stabilization of BCL-2 mRNA and Renders Pancreatic Cancer Cells Resistant to Therapeutics

Researchers report that PRMT1 expression is increased in pancreatic cancer tissues and associated with higher tumor grade, increased aggressiveness and worse prognosis.
[Cancer Research]
Abstract

Continue reading “Methylation of HSP70 Orchestrates Its Binding to and Stabilization of BCL-2 mRNA and Renders Pancreatic Cancer Cells Resistant to Therapeutics”

Bookmark

No account yet? Register

0
Share

Clinical Trials Rebound After COVID-19 Crash, but Can Enrollment Gains Continue?

For the hundreds of thousands of people enrolling in clinical trials every year—and for whom experimental therapies can offer a last hope—a new report provides some welcome news: Enrollment in clinical studies in the United States is on the rebound after disruptions caused by the COVID-19 pandemic.
[ScienceInsider]
Press Release

Continue reading “Clinical Trials Rebound After COVID-19 Crash, but Can Enrollment Gains Continue?”

Bookmark

No account yet? Register

0
Share

Science Money Slashed in EU’s €1.8-Trillion Budget Deal

A historic €1.8-trillion (US$2.1-trillion) budget deal reached by European Union (EU) leaders to fund its next seven years — and its recovery from the coronavirus pandemic — has left scientists and research advocates disappointed.
[Nature News]
Press Release

Continue reading “Science Money Slashed in EU’s €1.8-Trillion Budget Deal”

Bookmark

No account yet? Register

0
Share

Epigenetics in Modulating Immune Functions of Stromal and Immune Cells in the Tumor Microenvironment

The authors review recent studies demonstrating how specific epigenetic mechanisms drive aspects of stromal and immune cell differentiation with implications for the development of solid tumor therapeutics, focusing on the pancreatic ductal adenocarcinoma tumor microenvironment as a representative of solid tumors.
[Cellular & Molecular Immunology]
Abstract

Continue reading “Epigenetics in Modulating Immune Functions of Stromal and Immune Cells in the Tumor Microenvironment”

Bookmark

No account yet? Register

0
Share

CalciMedica and EpiPharma Enter into Research Collaboration to Discover and Develop CRAC Channel Inhibitor Therapies

CalciMedica and EpiPharma announced that they have entered into a collaboration agreement to use EpiPharma’s state-of-the-art pre-Clinical Drug Testing and Diagnostics Laboratory Platform to accelerate the discovery and development of CalciMedica’s CRAC channel inhibitor novel drug pipeline.
[CalciMedica]
Press Release

Continue reading “CalciMedica and EpiPharma Enter into Research Collaboration to Discover and Develop CRAC Channel Inhibitor Therapies”

Bookmark

No account yet? Register

0
Share

Tectorigenin Enhances PDX1 Expression and Protects Pancreatic β-Cells by Activating ERK and Reducing ER Stress

Investigators found that tectorigenin could suppress induced apoptosis and improved the viability of β-cells under glucotoxicity and lipotoxicity by activation of ERK and reduction of reactive oxygen species and endoplasmic reticulum stress.
[Journal of Biological Chemistry]
Yao, X., Li, K., Liang, C., Zhou, Z., Wang, J., Wang, S., Liu, L., Yu, C.-L., Song, Z.-B., Bao, Y.-L., Zheng, L.-H., Sun, Y., Wang, G., Huang, Y., Yi, J., Sun, L., & Li, Y. (2020). Tectorigenin enhances PDX1 expression and protects pancreatic β-cells by activating ERK and reducing ER stress. Journal of Biological Chemistry, jbc.RA120.012849. https://doi.org/10.1074/jbc.RA120.012849 Cite
Abstract

Continue reading “Tectorigenin Enhances PDX1 Expression and Protects Pancreatic β-Cells by Activating ERK and Reducing ER Stress”

Bookmark

No account yet? Register

0
Share

UAE1 Inhibition Mediates the Unfolded Protein Response, DNA Damage and Caspase-Dependent Cell Death in Pancreatic Cancer

Inhibition of ubiquitin activating enzyme 1 (UAE1) activity in response to TAK-243 led to an accumulation of misfolded proteins within the endoplasmic reticulum (ER), thereby aggravating ER stress, leading to DNA damage and arrest of cells in the G2/M phase of the cell cycle.
[Translational Oncology]
UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancer - ScienceDirect. (n.d.). Retrieved July 21, 2020, from https://www.sciencedirect.com/science/article/pii/S1936523320303260?via%3Dihub Cite
Full ArticleGraphical Abstract

Continue reading “UAE1 Inhibition Mediates the Unfolded Protein Response, DNA Damage and Caspase-Dependent Cell Death in Pancreatic Cancer”

Bookmark

No account yet? Register

0
Share

The USP22 Promotes the Growth of Cancer Cells through the DYRK1A in Pancreatic Ductal Adenocarcinoma

Scientists report that USP22 promoted the growth of pancreatic ductal adenocarcinoma cells by promoting the expression of dual-specificity tyrosine regulated kinase 1A.
[Gene]
Bai, Z., Du, Y., Cong, L., & Cheng, Y. (2020). The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma. Gene, 144960. https://doi.org/10.1016/j.gene.2020.144960 Cite
Abstract

Continue reading “The USP22 Promotes the Growth of Cancer Cells through the DYRK1A in Pancreatic Ductal Adenocarcinoma”

Bookmark

No account yet? Register

0
Share

Basal-Like and Classical Cells Coexist in Pancreatic Cancer Revealed by Single-Cell Analysis on Biopsy-Derived Pancreatic Cancer Organoids from the Classical Subtype

The authors performed single‐cell transcriptomic analyses using combinational barcoding exclusively on epithelial cells from six different classical pancreatic ductal adenocarcinoma patients obtained by Endoscopic Ultrasound with Fine Needle Aspiration.
[FASEB Journal]
Juiz, N., Elkaoutari, A., Bigonnet, M., Gayet, O., Roques, J., Nicolle, R., Iovanna, J., & Dusetti, N. (n.d.). Basal-like and classical cells coexist in pancreatic cancer revealed by single-cell analysis on biopsy-derived pancreatic cancer organoids from the classical subtype. The FASEB Journal, n/a(n/a). https://doi.org/10.1096/fj.202000363RR Cite
Full Article

Continue reading “Basal-Like and Classical Cells Coexist in Pancreatic Cancer Revealed by Single-Cell Analysis on Biopsy-Derived Pancreatic Cancer Organoids from the Classical Subtype”

Bookmark

No account yet? Register

0
Share

The Role of Genetic Polymorphism within PD-L1 Gene in Cancer

The expression of PD-L1 in tumors has been described in many histological types of cancer: melanoma, lung cancer, breast and ovarian, pancreatic and esophagus adenocarcinoma, kidney tumors and bladder cancers as well as in hematopoietic malignancies.
[Experimental and Molecular Pathology]
Kula, A., Dawidowicz, M., Kiczmer, P., Seńkowska, A. P., & Świętochowska, E. (2020). The role of genetic polymorphism within PD-L1 gene in cancer. Review. Experimental and Molecular Pathology, 104494. https://doi.org/10.1016/j.yexmp.2020.104494 Cite
Abstract

Continue reading “The Role of Genetic Polymorphism within PD-L1 Gene in Cancer”

Bookmark

No account yet? Register

0
Share
Share